DE3166374D1 - Protein hybrid having cytotoxicity and process for the preparation thereof - Google Patents
Protein hybrid having cytotoxicity and process for the preparation thereofInfo
- Publication number
- DE3166374D1 DE3166374D1 DE8181305997T DE3166374T DE3166374D1 DE 3166374 D1 DE3166374 D1 DE 3166374D1 DE 8181305997 T DE8181305997 T DE 8181305997T DE 3166374 T DE3166374 T DE 3166374T DE 3166374 D1 DE3166374 D1 DE 3166374D1
- Authority
- DE
- Germany
- Prior art keywords
- cytotoxicity
- preparation
- protein hybrid
- hybrid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003013 cytotoxicity Effects 0.000 title 1
- 231100000135 cytotoxicity Toxicity 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55180553A JPS57106626A (en) | 1980-12-22 | 1980-12-22 | Cytotoxic protein complex and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3166374D1 true DE3166374D1 (en) | 1984-10-31 |
Family
ID=16085283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8181305997T Expired DE3166374D1 (en) | 1980-12-22 | 1981-12-21 | Protein hybrid having cytotoxicity and process for the preparation thereof |
Country Status (4)
Country | Link |
---|---|
US (1) | US4368149A (en) |
EP (1) | EP0055575B1 (en) |
JP (1) | JPS57106626A (en) |
DE (1) | DE3166374D1 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5843926A (en) * | 1981-09-08 | 1983-03-14 | Suntory Ltd | Selective carcinostatic agent |
CA1203164A (en) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Antibody conjugates |
US4500637A (en) * | 1982-07-19 | 1985-02-19 | The United States Of America As Represented By The Department Of Health And Human Services | Prevention of graft versus host disease following bone marrow transplantation |
US4520226A (en) * | 1982-07-19 | 1985-05-28 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: ricin conjugates |
US4485093A (en) * | 1982-08-13 | 1984-11-27 | Runge Richard G | Immunotoxin conjugate which comprises arsanilic acid, useful for treating malignant tumors, particularly pancreatic cancer |
JPS59116232A (en) * | 1982-12-24 | 1984-07-05 | Teijin Ltd | Cell toxicity complex and its preparation |
US4664911A (en) * | 1983-06-21 | 1987-05-12 | Board Of Regents, University Of Texas System | Immunotoxin conjugates employing toxin B chain moieties |
US4894443A (en) * | 1984-02-08 | 1990-01-16 | Cetus Corporation | Toxin conjugates |
DE3584486D1 (en) * | 1984-02-08 | 1991-11-28 | Cetus Corp | TOXIN CONJUGATE. |
CA1314245C (en) * | 1984-05-23 | 1993-03-09 | Franz Jansen | Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators |
US4938898A (en) * | 1984-06-29 | 1990-07-03 | The Procter & Gamble Company | Alpha chlorination process employing antioxidants |
US4837003A (en) * | 1984-09-13 | 1989-06-06 | Mallinckrodt, Inc. | Radiolabeled antibody fragments |
US5256413A (en) * | 1985-01-08 | 1993-10-26 | The General Hospital Corporation | Method and use for site-specific activation of substances |
US4698420A (en) * | 1985-02-25 | 1987-10-06 | Xoma Corporation | Antibody hybrid molecules and process for their preparation |
US4911911A (en) * | 1985-12-20 | 1990-03-27 | Sanofi | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
US4911912A (en) * | 1985-12-20 | 1990-03-27 | Sanofi | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein |
US4880935A (en) * | 1986-07-11 | 1989-11-14 | Icrf (Patents) Limited | Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates |
US5149528A (en) * | 1987-04-10 | 1992-09-22 | Zymogenetics, Inc. | Cytotoxic protein from Trichosanthes kirilowii |
US5372812A (en) * | 1988-04-04 | 1994-12-13 | The General Hospital Corporation | Composition and method for acceleration of clot lysis |
US5582862A (en) * | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
US5609869A (en) * | 1988-08-19 | 1997-03-11 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
US5811265A (en) * | 1988-08-19 | 1998-09-22 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
US5162218A (en) * | 1988-11-18 | 1992-11-10 | The Regents Of The University Of California | Conjugated polypeptides and methods for their preparation |
US5612034A (en) * | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
ATE380871T1 (en) * | 1992-06-25 | 2007-12-15 | Univ Georgetown | PAPILLOMAVIRUS VACCINE |
US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
US5690935A (en) * | 1995-01-13 | 1997-11-25 | Regents Of The University Of Minnesota | Biotherapy of cancer by targeting TP-3/P80 |
JP2001515345A (en) * | 1996-09-20 | 2001-09-18 | ザ・ジェネラル・ホスピタル・コーポレイション | Compositions and methods for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
KR100509438B1 (en) * | 1997-04-01 | 2005-08-23 | 테라코스, 인코포레이티드 | Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
US8071844B1 (en) | 2007-09-13 | 2011-12-06 | Nutritional Health Institute Laboratories, Llc | Cultivated momordica species and extract thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2456224A1 (en) * | 1974-11-28 | 1976-08-12 | Karl Dr Med Theurer | Cancer therapy treatment agent - consists of immune globulin with tropism for embryonic or foetic antigens |
GB1541435A (en) * | 1975-02-04 | 1979-02-28 | Searle & Co | Immunological materials |
AU498384B2 (en) * | 1975-02-26 | 1979-03-08 | Yeda Research And Development Co. Ltd. | Anti-timor composition |
IL47372A (en) * | 1975-05-27 | 1979-10-31 | Yeda Res & Dev | Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same |
DE2862449D1 (en) * | 1977-08-22 | 1984-11-22 | Nat Res Dev | Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them |
FR2437213A1 (en) * | 1978-09-28 | 1980-04-25 | Cm Ind | CYTOTOXIC PRODUCTS FORMED BY COVALENT BINDING OF THE CHAIN TO RICIN WITH AN ANTIBODY AND THEIR PREPARATION METHOD |
US4315851A (en) * | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
JPS55136235A (en) * | 1979-04-09 | 1980-10-23 | Teijin Ltd | Antitumor protein complex and its preparation |
-
1980
- 1980-12-22 JP JP55180553A patent/JPS57106626A/en active Granted
-
1981
- 1981-12-16 US US06/331,342 patent/US4368149A/en not_active Expired - Fee Related
- 1981-12-21 DE DE8181305997T patent/DE3166374D1/en not_active Expired
- 1981-12-21 EP EP81305997A patent/EP0055575B1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0055575A1 (en) | 1982-07-07 |
EP0055575B1 (en) | 1984-09-26 |
JPS57106626A (en) | 1982-07-02 |
US4368149A (en) | 1983-01-11 |
JPH021129B2 (en) | 1990-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3166374D1 (en) | Protein hybrid having cytotoxicity and process for the preparation thereof | |
DE3067584D1 (en) | Antitumor protein hybrid and process for the preparation thereof | |
DE3166212D1 (en) | Cytotoxic protein hybrid and process for the preparation thereof | |
EP0115171A3 (en) | Conjugate having cytotoxicity and process for the preparation thereof | |
IL84653A0 (en) | Carboxybutenoic acids and processes for the preparation thereof | |
DE3171273D1 (en) | Immunoparticles and process for preparing the same | |
EP0112720A3 (en) | Conjugate having cytotoxicity and process for the preparation thereof | |
GB2120520B (en) | Protein product | |
IL67808A0 (en) | Plant-promoting preparations,process for the manufacture thereof and methods for the use thereof | |
DE3360650D1 (en) | Process for the preparation of o-toluidin and/or m-toluidin and/or p-toluidin | |
GB2087586B (en) | Sec-butylbiphenyl composition and process for preparing the same | |
DE3375789D1 (en) | Mannoglucan derivatives and process for preparing the same | |
DE3064923D1 (en) | Antitumor protein hybrid and process for the preparation thereof | |
GB2068957B (en) | Thioloesters and process for their preparation | |
ZA83231B (en) | Process for the preparation of -caprolactone | |
DE3364376D1 (en) | Isoindolazines, process for their preparation and their use | |
GB2124827B (en) | Thermistor- bolometer and method for the manufacture thereof | |
GB2083477B (en) | Endoproteinase-lys-c and process for the preparation thereof | |
DE3365690D1 (en) | Process for the preparation of 3,4,9,10-tetrathioperylene and 3,4,9,10-tetraselenoperylene | |
GB2146028B (en) | Spf-100 and process for the preparation thereof | |
DE3370796D1 (en) | Alpha-iminodiacetonitriles and methods for their preparation | |
DE3172032D1 (en) | 7-oxoprostacyclin derivatives and process for the preparation thereof | |
DE3369132D1 (en) | Process for the preparation of isomelamines, and their use | |
DE3365132D1 (en) | Process for the preparation of laminated products, and these products | |
DE3166862D1 (en) | Bromopolyfluoralkylthioethers and process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |